Bupropion Nitroso Impurity 2 - Request Quote
Bupropion Nitroso Impurity 2
| SZ CAT No: | SZ-B001093 |
| CAS No | NA |
| Mol.F. | C14H19ClN2O3 |
| Mol.Wt. | 298.8 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Bupropion Nitroso Impurity 2 is chemically N-(Tert-butyl)-N-(2-(3-chloro-5-ethyl-4-hydroxyphenyl)-2-oxoethyl)nitrous amide. Bupropion Nitroso Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Bupropion Nitroso Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bupropion.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Bupropion Nitroso Impurity 2
Purchase Bupropion Nitroso Impurity 2
Bupropion Nitroso Impurity 2 suppliers
Bupropion Nitroso Impurity 2 manufacturers
Bupropion Nitroso Impurity 2 price
Order Bupropion Nitroso Impurity 2
Enquire Bupropion Nitroso Impurity 2
Bupropion Nitroso Impurity 2 cost
Bupropion Nitroso Impurity 2 Supplier
Bupropion Nitroso Impurity 2 Distributor
Bupropion Nitroso Impurity 2 for Method Validation
Bupropion Reference Standard
Bupropion Nitroso Impurity 2 for ANDA Filing
Bupropion Nitroso Impurity 2 for Forced Degradation Studies
Bupropion Nitroso Impurity 2 Identification Standards
Bupropion Nitroso Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.